0 valutazioniIl 0% ha trovato utile questo documento (0 voti)
5 visualizzazioni4 pagine
Alzheimer disease (AD) is a progressive neurodegenerative disorder affecting more than 37 million people worldwide. Patients with AD often experience language and visuospatial dysfunction in addition to neuropsychiatric symptoms such as anxiety, "d"depression, apathy, and agitation.
Alzheimer disease (AD) is a progressive neurodegenerative disorder affecting more than 37 million people worldwide. Patients with AD often experience language and visuospatial dysfunction in addition to neuropsychiatric symptoms such as anxiety, "d"depression, apathy, and agitation.
Alzheimer disease (AD) is a progressive neurodegenerative disorder affecting more than 37 million people worldwide. Patients with AD often experience language and visuospatial dysfunction in addition to neuropsychiatric symptoms such as anxiety, "d"depression, apathy, and agitation.
Meharry Medical College Adjunct Faculty Vanderbilt Medical School Chief of neurology service: Nashville General Hospital
Most common form of dementia - Alzheimer disease (AD) was first described more than 100 years ago.
Alzheimer disease (AD) is a progressive neurodegenerative disorder affecting more than 37 million people worldwide and is increasing in incidence based on its primary risk factor, which is advancing age. While memory concerns predominate, patients with AD often experience language and visuospatial dysfunction in addition to neuropsychiatric symptoms such as anxiety, d- depression, apathy, and agitation in reality a continuum Depression Pseudo D Delirium- the other D Endocrine Disorders Thyroid disease Vitamin B12 deficiency Other: Sleep disorders: OSA, RBD Epilepsy associated Occasionally other like HIV Normal Pressure Hydrocephalus NPH - rare